Results 111 to 120 of about 7,770 (204)

Advances in Biosimilars: A Systematic Review of Machine Learning Applications. [PDF]

Pharmaceuticals (Basel)
Duarte V, Bas TG.
europepmc   +1 more source

Biosimilar anti-vascular endothelial growth factor agents: Clinical outcomes, safety, and cost-effectiveness in India. [PDF]

Indian J Ophthalmol
Chakraborty D, Sinha TK, Boral S, Das A.
europepmc   +1 more source

Patient out-of-pocket costs and rheumatology biosimilar competition. [PDF]

J Manag Care Spec Pharm
Dayer VW, Hansen RN, Roth J, Jofre-Bonet M, Sullivan SD.   +4 more
europepmc   +1 more source

Integration of Ustekinumab Biosimilars into Inflammatory Bowel Disease Care: Evidence, Implementation, and Patient-Centered Considerations. [PDF]

Adv Ther
Piche SL, Becker MD, Bhat S, Huang LL, Kane SV.   +4 more
europepmc   +1 more source

Developing a framework to assess off-patent medicines policies in Latin America and the Caribbean. [PDF]

J Pharm Policy Pract
Espín J, Palacio-Ciro S, Amaris A, Gongora-Salazar P, Wirtz VJ.   +4 more
europepmc   +1 more source

Biosimilars [PDF]

Zeitschrift für Rheumatologie, 2015
G.-R. Burmester, U. Müller-Ladner
openaire   +1 more source

Biological Medicines, Biosimilars and Their Automatic Substitution: Concerns, Knowledge and Information Needs of People with Diabetes. [PDF]

BioDrugs
Kouhia M, Linden K, Metso S, Pimiä E, Koski S, Aarnio E, Zacheus T, Hämeen-Anttila K.   +7 more
europepmc   +1 more source

Perceptions and clinical use of biosimilars among rheumatologists in ArLAR countries: a cross-sectional survey. [PDF]

Front Med (Lausanne)
Adnan A, Awadh NI, Humadi YA, Gorial FI, Ziade N, Younis AA, Hmamouchi I, El Kibbi L, Halabi H, Haouichat C, Masri BK, Omer EOH, Shimal AA, Al-Obaidi AD, Jassim NA.   +14 more
europepmc   +1 more source

Biosimilars in Adult and Pediatric Noninfectious Uveitis. [PDF]

Clin Ophthalmol
Ploeger CG, Carvalho Soares Valentim C, Guner ME, Kabaalioglu Guner M.   +3 more
europepmc   +1 more source

Pragmatic health technology appraisals of biosimilars: a pilot case study of bevacizumab in colorectal cancer for NICE. [PDF]

Cost Eff Resour Alloc
Stevenson MD, Mon-Yee M, Forsyth JE, Montazeri A, Saunders MP.   +4 more
europepmc   +1 more source